Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

424B5 - Prospectus [Rule 424(b)(5)]

Form Type: 424B5

Filing Date: 2018-02-21

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2018-02-21

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2018-02-15

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2018-02-13

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2018-02-06

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2018-01-29

View Filing

PRE 14A - Other preliminary proxy statements

Form Type: PRE 14A

Filing Date: 2018-01-25

View Filing

S-8 - Securities to be offered to employees in employee benefit plans

Form Type: S-8

Filing Date: 2018-01-09

View Filing

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K

Filing Date: 2017-12-21

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2017-12-20

View Filing